University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Radial Artery Dilation Study: The Effect of Topical Administration of Nitroglycerin and Lidocaine Versus Lidocaine Alone of the Radial Artery Diameter

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Nitroglycerin 15mg
Drug: Nitroglycerin 30mg
Drug: Lidocaine 20mg
Drug: Lidocaine 40mg
Drug: Placebo

First Posted Date: 2008-05-29

Last Posted Date: 2020-03-06

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 19

Registration Number: NCT00686231

Locations: 🇺🇸
UCSF Medical Center, San Francisco, California, United States

Symptom Management After Breast Cancer Surgery

Phase 4

Completed

Conditions: Neuropathic Pain
Postmastectomy Pain

Interventions: Drug: Lidoderm patch
Drug: Placebo patch

First Posted Date: 2008-05-29

Last Posted Date: 2018-06-28

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 21

Registration Number: NCT00686127

Locations: 🇺🇸
UCSF Comprehensive Cancer Center, San Francisco, California, United States

Evaluation of a Decision Assisting Tool for Prenatal Testing

Not Applicable

Completed

Conditions: Pregnancy

Interventions: Other: PT Tool - interactive, computerized, prenatal testing decision tool
Other: Control - computerized age-appropriate prenatal testing educational brochure

First Posted Date: 2008-05-29

Last Posted Date: 2008-05-29

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 494

Registration Number: NCT00686062

Locations: 🇺🇸
UCSF, San Francisco, California, United States

Harnessing Health IT for Self-Management Support and Medication Activation in a Medicaid Health Plan

Not Applicable

Completed

Conditions: Diabetes

Interventions: Behavioral: ATSM Intervention

First Posted Date: 2008-05-23

Last Posted Date: 2013-05-15

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 362

Registration Number: NCT00683020

Locations: 🇺🇸
Center for Vulnerable Populations, San Francisco, California, United States

PTH & Ibandronate Combination Study (PICS)

Phase 2

Completed

Conditions: Osteoporosis

Interventions: Drug: PTH(1-84)
Drug: Ibandronate
Other: Placebo injection
Other: Placebo pills

First Posted Date: 2008-05-23

Last Posted Date: 2013-11-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 44

Registration Number: NCT00683163

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Microarray Analysis of Sinus Samples From Patients With and Without Chronic Rhinosinusitis

Not Applicable

Completed

Conditions: Maxillary Sinusitis

Interventions: Procedure: Specimen collection

First Posted Date: 2008-05-23

Last Posted Date: 2020-02-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT00683371

Locations: 🇺🇸
University of California, San Francisco, Dept of Otolaryngology-HNS, San Francisco, California, United States

Mild Pulmonary Function Changes With Transfusion

Completed

Conditions: Transfusion Reactions

First Posted Date: 2008-05-21

Last Posted Date: 2015-01-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 92

Registration Number: NCT00681954

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: GM-CSF

First Posted Date: 2008-05-15

Last Posted Date: 2017-08-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT00678054

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis

Not Applicable

Completed

Conditions: Moderate to Severe Psoriasis

Interventions: Drug: Intralesional Alefacept

First Posted Date: 2008-05-15

Last Posted Date: 2019-04-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 18

Registration Number: NCT00678470

Locations: 🇺🇸
UCSF Psoriasis and Skin Treatment Center, San Francisco, California, United States

Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) in Non Metastatic Recurrent Prostate Cancer

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Drug: Nordihydroguaiaretic Acid (NDGA)

First Posted Date: 2008-05-15

Last Posted Date: 2014-04-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 12

Registration Number: NCT00678015

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy